Infection and Immunity
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.4 | Q2 | 66.0% | 1.171 | Q1 | 87.6% |
| 2024 | 2.8 | Q2 | 59.1% | 1.054 | Q1 | 85.5% |
| 2023 | 2.9 | Q2 | 60.0% | 1.042 | Q1 | 86.5% |
| 2022 | 3.1 | Q3 | 50.9% | 0.923 | Q1 | 84.4% |
| 2021 | 3.6 | Q3 | 58.5% | 1.139 | Q1 | 89.1% |
| 2020 | — | — | 1.508 | Q1 | 92.4% | |
| 2019 | — | — | 1.581 | Q1 | 93.3% | |
| 2018 | — | — | 1.591 | Q1 | 92.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0019-9567
ISSN
1098-5522
country
UScoverage
1970-2026